| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |